Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
基本信息
- 批准号:10410509
- 负责人:
- 金额:$ 57.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-exoribonucleaseActive SitesAffectBacteriaBacterial InfectionsBacterial PhysiologyBiochemicalBiological AssayBypassCatalysisCatalytic DomainCathetersCell Culture TechniquesCell physiologyChronicComplementComplexCrystallizationCuesDataDefectDegradation PathwayDinucleoside PhosphatesEnzymesExcisionExoribonucleasesFamilyFeedbackGammaproteobacteriaGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrantHydrolysisInfectionInterdisciplinary StudyKidneyKnowledgeLengthMicrobial BiofilmsMolecularNucleotidesOligonucleotidesOligoribonucleotidesOperonOrganismPathway interactionsPeriodicityPhenotypePhosphodiesterase IPhysiologicalProcessPropertyProteinsPseudomonas aeruginosaPseudomonas aeruginosa infectionPublicationsRNARNA DegradationRecyclingRegulationRibonucleasesRoleSecond Messenger SystemsSignal TransductionSignal Transduction PathwaySignaling MoleculeStructureStructure-Activity RelationshipTestingTimeType III Secretion System PathwayUp-RegulationVirulenceX-Ray Crystallographybasecatheter associated UTIchronic infectiondetection methoddiguanylate cyclaseendonucleasegene functionhuman pathogenin vivomembermouse modelmutantnanooligoribonucleasepathogenic bacteriaphosphoric diester hydrolasepreferencepyochelinresponsetripolyphosphate
项目摘要
ABSTRACT
!
Bacteria use cyclic-di-GMP (c-di-GMP) as a secondary signaling molecule to relay environmental cues to
phenotypic changes, including biofilm formation and virulence. C-di-GMP is degraded in two sequential
enzymatic steps: 1. Linearization to pGpG by phosphodiesterase-A (PDE-A) and 2. Hydrolysis of pGpG to
GMP by PDE-B. While PDE-A enzymes have been studied more extensively, we only recently identified
oligoribonuclase (Orn) as the primary PDE-B in Pseudomonas aeruginosa. A P. aeruginosa ∆orn mutant
has elevated levels of pGpG and c-di-GMP, resulting in hyperbiofilm formation. Notably, our preliminary
data indicate that the ∆orn mutant is also unable to disseminate in a murine model of catheter-associated
urinary tract infection (CAUTI). However, the underlying molecular mechanisms remain enigmatic. Orn is
described as a 3' to 5' exoribonuclease that is thought to cleave short oligonucleotides from 2-7 residues
in length, completing RNA degradation. Orn is unique amongst exoribonucleases since it is the only
member known to be essential in many gammaproteobacteria. Based on our data, Orn appears to function
at the intersection between RNA degradation and c-di-GMP signaling, but how an enzyme regulates both
dinucleotide signaling and global RNA pools is poorly understood. To bridge this fundamental knowledge
gap regarding Orn's unique function, we developed an interdisciplinary research plan. We hypothesize
that Orn's enzymatic and physiological function deviates from the popular view that Orn acts as rather
unspecific nano-RNase. Instead, based on new structures of Orn in complex with pGpG that reveal a
constrained catalytic site optimized for dinucleotide substrates, we propose that Orn functions primarily as
an endonuclease for dinucleotides. Further preliminary data demonstrate that organisms that do not
encode orn have additional genes that function as PDE-B. Our previous publications and preliminary data
form the scientific premise underlying our overarching hypothesis that PDE-Bs are dinucleotidases that
regulate c-di-GMP signaling and chronic infection. To test our hypothesis, we will complete the following
aims: 1. Characterize the molecular basis for substrate recognition and catalysis by PDE-Bs; 2. Elucidate
Orn substrate preferences and effects on oligonucleotide pools; and 3. Determine the pathways regulated
by Orn during chronic P. aeruginosa catheter-associated urinary tract infections. Results from our
proposed studies will reveal the structural basis for PDE-Bs preference for dinucleotides, provide
biochemical evidence that PDE-Bs are dinucleotidases, reveal the impact of loss of PDE-Bs on the
accumulation of diucleotide and oligonucleotide pools, and uncover altered regulation leading to defects
during chronic infections. The impact of the grant is to understand the intersection of RNA degradation and
cyclic dinucleotide signaling and to assign a defined function for PDE-Bs that is consistent with their
observed physiological roles in signaling and infection.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENT T LEE其他文献
VINCENT T LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENT T LEE', 18)}}的其他基金
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10614436 - 财政年份:2022
- 资助金额:
$ 57.9万 - 项目类别:
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10371521 - 财政年份:2022
- 资助金额:
$ 57.9万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10620734 - 财政年份:2019
- 资助金额:
$ 57.9万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10163122 - 财政年份:2019
- 资助金额:
$ 57.9万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8176077 - 财政年份:2011
- 资助金额:
$ 57.9万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8263370 - 财政年份:2011
- 资助金额:
$ 57.9万 - 项目类别:
Small molecule inhibitors of bacterial secretion system
细菌分泌系统小分子抑制剂
- 批准号:
7337974 - 财政年份:2007
- 资助金额:
$ 57.9万 - 项目类别:
相似海外基金
Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
- 批准号:
10713523 - 财政年份:2023
- 资助金额:
$ 57.9万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10525101 - 财政年份:2022
- 资助金额:
$ 57.9万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10624457 - 财政年份:2022
- 资助金额:
$ 57.9万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10215766 - 财政年份:2021
- 资助金额:
$ 57.9万 - 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
- 批准号:
10238324 - 财政年份:2021
- 资助金额:
$ 57.9万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10656174 - 财政年份:2021
- 资助金额:
$ 57.9万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10370384 - 财政年份:2021
- 资助金额:
$ 57.9万 - 项目类别:
Exploiting the SARS-CoV-2 nsp14 3'-5'-exoribonuclease as a target for antiviral chemotherapy
利用 SARS-CoV-2 nsp14 3-5-核糖核酸外切酶作为抗病毒化疗的靶点
- 批准号:
MR/V036904/1 - 财政年份:2020
- 资助金额:
$ 57.9万 - 项目类别:
Research Grant
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
剖析冠状病毒校对核糖核酸酶在 RNA 重组中的作用
- 批准号:
10268982 - 财政年份:2020
- 资助金额:
$ 57.9万 - 项目类别:
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
- 批准号:
9750410 - 财政年份:2018
- 资助金额:
$ 57.9万 - 项目类别: